125 related articles for article (PubMed ID: 32910125)
1. Toward supramolecular nanozymes for the photocatalytic activation of Pt(IV) anticancer prodrugs.
Mazzei LF; Martínez Á; Trevisan L; Rosa-Gastaldo D; Cortajarena AL; Mancin F; Salassa L
Chem Commun (Camb); 2020 Sep; 56(72):10461-10464. PubMed ID: 32910125
[TBL] [Abstract][Full Text] [Related]
2. Complexes of oxoplatin with rhein and ferulic acid ligands as platinum(iv) prodrugs with high anti-tumor activity.
Tan MX; Wang ZF; Qin QP; Zou BQ; Liang H
Dalton Trans; 2020 Feb; 49(5):1613-1619. PubMed ID: 31942585
[TBL] [Abstract][Full Text] [Related]
3. Multi-Acting Mitochondria-Targeted Platinum(IV) Prodrugs of Kiteplatin with α-Lipoic Acid in the Axial Positions.
Savino S; Marzano C; Gandin V; Hoeschele JD; Natile G; Margiotta N
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30011897
[TBL] [Abstract][Full Text] [Related]
4. Activation of Platinum(IV) Prodrugs by Cytochrome c and Characterization of the Protein Binding Sites.
Lasorsa A; Stuchlíková O; Brabec V; Natile G; Arnesano F
Mol Pharm; 2016 Sep; 13(9):3216-23. PubMed ID: 27505350
[TBL] [Abstract][Full Text] [Related]
5. Kinetics and mechanism for reduction of the anticancer prodrug trans,trans,trans-[PtCl2(OH)2(c-C6H11NH2)(NH3)] (JM335) by thiols.
Lemma K; Shi T; Elding LI
Inorg Chem; 2000 Apr; 39(8):1728-34. PubMed ID: 12526561
[TBL] [Abstract][Full Text] [Related]
6. Oxidation of 3,6-dioxa-1,8-octanedithiol by platinum(IV) anticancer prodrug and model complex: kinetic and mechanistic studies.
Huo S; Shen S; Liu D; Shi T
J Phys Chem B; 2012 Jun; 116(22):6522-8. PubMed ID: 22574871
[TBL] [Abstract][Full Text] [Related]
7. Biological activity of Pt
Alonso-de Castro S; Terenzi A; Hager S; Englinger B; Faraone A; Martínez JC; Galanski MS; Keppler BK; Berger W; Salassa L
Sci Rep; 2018 Nov; 8(1):17198. PubMed ID: 30464209
[TBL] [Abstract][Full Text] [Related]
8. Bioorthogonal Catalytic Activation of Platinum and Ruthenium Anticancer Complexes by FAD and Flavoproteins.
Alonso-de Castro S; Cortajarena AL; López-Gallego F; Salassa L
Angew Chem Int Ed Engl; 2018 Mar; 57(12):3143-3147. PubMed ID: 29359850
[TBL] [Abstract][Full Text] [Related]
9. Spin-labelled photo-cytotoxic diazido platinum(iv) anticancer complex.
Venkatesh V; Wedge CJ; Romero-Canelón I; Habtemariam A; Sadler PJ
Dalton Trans; 2016 Aug; 45(33):13034-7. PubMed ID: 27189101
[TBL] [Abstract][Full Text] [Related]
10. Nanoparticles of metal-organic cages designed to encapsulate platinum-based anticancer agents.
Yue Z; Wang H; Bowers DJ; Gao M; Stilgenbauer M; Nielsen F; Shelley JT; Zheng YR
Dalton Trans; 2018 Jan; 47(3):670-674. PubMed ID: 29257160
[TBL] [Abstract][Full Text] [Related]
11. An upconversion nanoplatform for simultaneous photodynamic therapy and Pt chemotherapy to combat cisplatin resistance.
Ai F; Sun T; Xu Z; Wang Z; Kong W; To MW; Wang F; Zhu G
Dalton Trans; 2016 Aug; 45(33):13052-60. PubMed ID: 27430044
[TBL] [Abstract][Full Text] [Related]
12. Cancer-Specific, Intracellular, Reductive Activation of Anticancer Pt
Reshetnikov V; Daum S; Mokhir A
Chemistry; 2017 Apr; 23(24):5678-5681. PubMed ID: 28319647
[TBL] [Abstract][Full Text] [Related]
13. Novel synthesis of platinum complexes and their intracellular delivery to tumor cells by means of magnetic nanoparticles.
Quarta A; Amorín M; Aldegunde MJ; Blasi L; Ragusa A; Nitti S; Pugliese G; Gigli G; Granja JR; Pellegrino T
Nanoscale; 2019 Dec; 11(48):23482-23497. PubMed ID: 31808496
[TBL] [Abstract][Full Text] [Related]
14. Photoinduced Reduction of Novel Dual-Action Riboplatin Pt(IV) Prodrug.
Krasnovskaya OO; Akasov RA; Spector DV; Pavlov KG; Bubley AA; Kuzmin VA; Kostyukov AA; Khaydukov EV; Lopatukhina EV; Semkina AS; Vlasova KY; Sypalov SA; Erofeev AS; Gorelkin PV; Vaneev AN; Nikitina VN; Skvortsov DA; Ipatova DA; Mazur DM; Zyk NV; Sakharov DA; Majouga AG; Beloglazkina EK
ACS Appl Mater Interfaces; 2023 Mar; 15(10):12882-12894. PubMed ID: 36854172
[TBL] [Abstract][Full Text] [Related]
15. A Cancer Cell-Selective and Low-Toxic Bifunctional Heterodinuclear Pt(IV)-Ru(II) Anticancer Prodrug.
Ma L; Lin X; Li C; Xu Z; Chan CY; Tse MK; Shi P; Zhu G
Inorg Chem; 2018 Mar; 57(5):2917-2924. PubMed ID: 29436828
[TBL] [Abstract][Full Text] [Related]
16. Targeted iron nanoparticles with platinum-(IV) prodrugs and anti-EZH2 siRNA show great synergy in combating drug resistance in vitro and in vivo.
Yu C; Ding B; Zhang X; Deng X; Deng K; Cheng Z; Xing B; Jin D; Ma P; Lin J
Biomaterials; 2018 Feb; 155():112-123. PubMed ID: 29175080
[TBL] [Abstract][Full Text] [Related]
17. An Anticancer Pt
Kostrhunova H; Petruzzella E; Gibson D; Kasparkova J; Brabec V
Chemistry; 2019 Apr; 25(20):5235-5245. PubMed ID: 30740808
[TBL] [Abstract][Full Text] [Related]
18. A Platinum(IV) Anticancer Prodrug Targeting Nucleotide Excision Repair To Overcome Cisplatin Resistance.
Wang Z; Xu Z; Zhu G
Angew Chem Int Ed Engl; 2016 Dec; 55(50):15564-15568. PubMed ID: 27736029
[TBL] [Abstract][Full Text] [Related]
19. Activation of Platinum(IV) Prodrugs By Motexafin Gadolinium as a Redox Mediator.
Thiabaud G; McCall R; He G; Arambula JF; Siddik ZH; Sessler JL
Angew Chem Int Ed Engl; 2016 Oct; 55(41):12626-31. PubMed ID: 27377046
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, crystal structure, studies in solution and cytotoxicity of two new fluorescent platinum(II) compounds containing anthracene derivatives as a carrier ligand.
Marqués-Gallego P; den Dulk H; Brouwer J; Kooijman H; Spek AL; Roubeau O; Teat SJ; Reedijk J
Inorg Chem; 2008 Dec; 47(23):11171-9. PubMed ID: 18975941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
